News
10-22-2018, 12:00 AM
Immunotherapy improves survival in some patients with metastatic triple negative breast cancer, according to late-breaking results from the IMpassion130 trial reported at the ESMO 2018 Congress in Munich.
More... (https://www.news-medical.net/news/20181022/Immunotherapy-increases-survival-in-some-patients-with-metastatic-triple-negative-breast-cancer.aspx)
More... (https://www.news-medical.net/news/20181022/Immunotherapy-increases-survival-in-some-patients-with-metastatic-triple-negative-breast-cancer.aspx)